市場調查報告書
商品編碼
1438555
全球腦機介面 - 市場佔有率分析、產業趨勢與統計、成長預測(2024 - 2029)Global Brain-computer Interface - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029) |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2024年全球腦機介面市場規模將達20億美元,預計2029年將達到32.5億美元,在預測期間(2024-2029年)CAGR為10.29%。
由於製造和供應鏈活動的封鎖和中斷,COVID-19 對市場的最初影響是巨大的。然而,COVID-19 大流行加速了新技術的部署,同時也增加了最終用戶對新技術的依賴。腦機介面(BCI)技術擴大用於治療許多患有身體障礙的老年患者,將反映老年人意圖的特定訊號特徵轉化為命令,使他們能夠提高運動和認知能力,從而可以使用作為COVID-19 期間復健醫學的一種有前景的工具,可能會對市場成長產生積極影響。根據 2021 年 9 月發布的報告《輪椅運動與控制中基於運動影像腦電圖的腦機介面:系統文獻回顧》,COVID-19 為開發和實施腦機介面、生物醫學解決方案、輔助技術(AT ),以幫助嚴重殘障人士參與日常生活。
此外,由於神經退化性疾病的盛行率不斷增加、公司為改進腦機介面技術而進行的研發活動不斷增加以及設備小型化等各種技術進步,腦機介面市場可能會快速成長。
在所有因素中,神經退化性疾病的盛行率不斷增加是預計在預測期內推動腦機介面市場的最重要因素。根據帕金森基金會預測,2020年美國可能有超過93萬人患有帕金森氏症。而且,該基金會的報告也預測,到2020年,帕金森氏症患者數量預計將增加至120萬人。到2030年。這意味著自2010 年以來,帕金森氏症患病率預計將增加約1.8 倍,突顯需要針對該患者群體最佳化護理和治療策略,以減輕護理人員的護理負擔並減輕醫療保健系統的經濟負擔。因此,大多數這些患者最終需要持續的護理和監測或幫助,這可以透過使用腦機介面設備來實現。
此外,各公司研發活動的增加以及政府對腦機介面技術開發和新應用的投資的增加是預測期內推動市場成長的主要因素。例如,根據2020 年8 月發表的一篇題為《腦機介面企業融資》的文章,澳洲聯邦政府向名為Bionic Vision Australia 的研究財團提供了4,200 萬美元的資助,用於開發仿生視覺技術,這是一種大腦-電腦介面技術。該技術後來轉讓給 Bionic Vision Technologies,該公司從私人資助者那裡籌集了 1800 萬美元,大概用於進一步的臨床試驗和進一步的開發。世界各地政府支持技術創新的投資正在增加,這將推動全球市場的成長。
然而,腦機介面設備的高成本和缺乏實施系統的專業知識是阻礙市場成長的主要因素。
從類型來看,非侵入性腦機介面領域預計將顯著成長。由於該技術的高適用性和日益增加的神經系統疾病,非侵入性腦機介面領域被發現在整個市場中佔據主導地位。基於腦電圖的非侵入性腦機介面設備的開發有望提高BCI技術的主流可及性。此外,批准數量的成長預計也將補充市場的成長。例如,2021 年 4 月,美國食品藥物管理局 (FDA) 批准使用腦機介面設備來幫助手部、手腕和手臂殘疾的中風患者復原。 IpsiHand 上肢復健系統 (IpsiHand System) 由 Neurolutions 開發,使用非侵入性腦電圖 (EEG) 電極(而不是植入大腦的更典型的電極)來記錄大腦活動。
此外,與非侵入性腦機介面領域相關的研發活動和產品發布的增加也促進了市場的成長。例如,2020 年1 月,總部位於巴黎的腦機介面(BCI)新創公司NextMind 在CES 上推出了一款神經介面開發套件,售價400 美元。該設備是一種非侵入性腦電圖(EEG ),是一種很好的神經介面開發工具包。- 建立了從顱骨外部測量神經元電壓波動的方法。
因此,由於上述因素,預計該區隔市場在預測期內將顯著成長。
預計亞太地區腦機介面市場將在預測期內顯著成長,特別是在日本和中國等發展中國家。該市場的特點是技術進步,預計將為醫護人員和個人提供更好的選擇。
此外,2020年,中國研究人員開發了基於憶阻器陣列的神經訊號分析系統,為高效腦機介面鋪平了道路,並利用該系統實現了癲癇相關神經訊號的過濾和識別,達到了超過93 %。該系統借鑒了電子和醫學研究領域研究人員的工作成果。預計這些發展將對亞太地區市場的成長產生正面影響。
此外,新技術涵蓋了旨在徹底改變安全、自動化和通訊體驗的廣泛應用程式。例如,2021年,天津大學的一個神經工程團隊正在研發第二代「BrainTalker」晶片,晶片功耗更低,系統單晶片整合度更高,研究人員報告指出:他們能夠從腦電圖訊號中捕獲「高品質」的大腦意圖,從而滿足應用需求。
因此,由於上述因素,預計市場在預測期內將顯著成長。
腦機介面市場競爭適中,擁有多元化的國際、區域和本地參與者。然而,一些大型國際企業,如 Natus Medical Incorporated、Compumedics Ltd、Emotive Incorporation、g.tec Medical Engineering GmbH 和 NeuroSky,憑藉其品牌形象和市場覆蓋範圍,在市場上佔據主導地位。這些公司投資新技術,為客戶提供數位化變革。
The Global Brain-computer Interface Market size is estimated at USD 2 billion in 2024, and is expected to reach USD 3.25 billion by 2029, growing at a CAGR of 10.29% during the forecast period (2024-2029).
The initial impact of COVID-19 on the market was significant owing to lockdowns and disruptions in manufacturing and supply chain activities. However, the COVID-19 pandemic has hastened the deployment of new technologies while also increasing end users' reliance on them. The rising usage of brain-computer interface (BCI) technology for the treatment of many elderly patients suffering from physical impairments to translate specific signal features that reflect the elderly's intent into commands and enable them to improve their motor and cognitive abilities, which can be used as a promising tool in rehabilitation medicine during COVID-19, is likely to have a positive impact on the market growth. According to the report "Motor-Imagery EEG-Based BCIs in Wheelchair Movement and Control: A Systematic Literature Review" published in September 2021, the COVID-19 has created an opportunity for the development and implementation of innovative devices like BCIs, biomedical solutions, and assistive technologies (AT) to facilitate people with severe disabilities regarding their participation in daily life.
Further, the brain-computer interface market is likely to show rapid growth due to the increasing prevalence of neurodegenerative disorders, rising R&D activities by the companies to improve the brain-computer interface technology and various technological advancements such as miniaturization of devices.
Among all the factors, the increasing prevalence of neurodegenerative disorders is the foremost factor expected to drive the brain-computer interface market over the forecast period. According to the Parkinson's Foundation, more than 930,000 people in the United States were likely to be suffering from Parkinson's disease in 2020. Moreover, the report by the foundation also predicted that the number of people with Parkinson's disease is expected to rise to 1.2 million by 2030. This represents a projected increase of about 1.8 times in Parkinson's prevalence since 2010, highlighting the need for optimized care and treatment strategies for this patient population to diminish the burden of care on caregivers and ease the economic burden on the healthcare system. Therefore, most of these patients eventually require continuous care and monitoring or help, which can be facilitated by the use of brain-computer interface devices.
Moreover, the increase in R&D activities by various companies and investments from the governments in brain-computer interface technology development and new applications is a chief factor that may promote the growth of the market during the forecast period. For instance, according to an article titled "Funding for Brain-Computer Interface Ventures" published in August 2020, the Australian Federal Government awarded a USD 42 million grant to a research consortium called Bionic Vision Australia to develop bionic vision technology, a type of brain-computer interface technology. The technology was later transferred to Bionic Vision Technologies, which raised USD 18 million from private funders, presumably for further clinical trials and further development. Such investments by governments supporting technological innovation are increasing across the world, which will drive the market's growth globally.
However, the high cost of brain-computer interface devices and a lack of expertise in implementing the systems are the major factors hindering the market's growth.
By type, the non-invasive brain-computer interface segment is expected to witness significant growth. The non-invasive brain-computer interface segment is found to dominate the overall market owing to the high applicability of the technology and increasing neurological disorders. The development of non-invasive brain-computer interface devices based on EEG is expected to increase the mainstream accessibility of BCI technology. Moreover, growth in the number of approvals is also expected to supplement the market's growth. For instance, in April 2021, the United States Food and Drug Administration (FDA) approved the use of a brain-computer interface device to aid stroke patients with hand, wrist, and arm disabilities in their recovery. The IpsiHand Upper Extremity Rehabilitation System (IpsiHand System) was developed by Neurolutions and records brain activity using non-invasive electroencephalography (EEG) electrodes (rather than the more typical electrodes implanted into the brain).
Also, the increasing research and development activities and product launches pertaining to the non-invasive brain-computer interface segment are contributing to the market's growth. For instance, in January 2020, NextMind, a Paris-based brain-computer interface (BCI) startup, launched a neural interface dev kit at CES for USD 400. This device is a non-invasive electroencephalogram (EEG), which is a well-established method of measuring the voltage fluctuations of neurons from outside the skull.
Thus, due to the above-mentioned factors, the segment is expected to witness significant growth during the forecast period.
The Asia-Pacific brain-computer interface market is anticipated to grow significantly over the forecast period, particularly in developing countries such as Japan and China. The market is characterized by technological advancements that are expected to result in the availability of better options for healthcare personnel and individuals.
Furthermore, in 2020, Chinese researchers developed a neural signal analysis system with memristor arrays, paving the way for high-efficiency brain-machine interfaces, and used the system to implement the filtering and identification of epilepsy-related neural signals, achieving an accuracy of over 93%. The system draws upon work from researchers in the fields of electronics and medical research. Such developments are anticipated to have a positive impact on the growth of the market in the Asia-Pacific region.
Additionally, new technology encompasses a wide array of applications designed to revolutionize security, automation, and communication experiences. For instance, in 2021, a neuro-engineering team at Tianjin University was working on the research and development of the second-generation "BrainTalker" chip, which uses less power and offers higher system-on-chip integration, and the researchers reported that they were able to capture "good-quality" brain intentions from electroencephalogram signals that could satisfy application demands.
Thus, due to the above-mentioned factors, the market is expected to witness significant growth over the forecast period.
The brain-computer interface market is moderately competitive and has the presence of well-diversified international, regional, and local players. However, some big international players, such as Natus Medical Incorporated, Compumedics Ltd, Emotive Incorporation, g.tec medical engineering GmbH, and NeuroSky, dominate the market owing to their brand image and market reach. The companies are found investing in new technologies to provide a digital change to their customers.
g.tec medical engineering GmbH